Should you buy Repligen and ResMed stocks?
Repligen (NASDAQ: RGEN) and ResMed (NYSE: RMD) are two stocks which could fit that bill with their proven track records and growing opportunities. Repligen offers a unique way to invest in the healthcare space.
Is ResMed (Rs) stock a buy on rising relative strength?
The Relative Strength (RS) Rating for Resmed stock climbed into a new percentile Friday, as it got a lift from 64 to 75. When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.
What does ResMed's dividend look like?
ResMed pays an annual dividend of $1.68 per share and currently has a dividend yield of 0.66%. ResMed does not yet have a strong track record of dividend growth. The dividend payout ratio of ResMed is 47.32%.
Who sold RMD stock in the last quarter?
RMD stock was sold by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., Mitsubishi UFJ Trust & Banking Corp, Geode Capital Management LLC, Panagora Asset Management Inc., Invesco Ltd., Bank of America Corp DE, Capital World Investors, and KBC Group NV.
How has Repro-Med Systems' stock price performed in 2022?
Repro-Med Systems' stock was trading at $3.00 at the beginning of the year. Since then, REPR stock has decreased by 28.0% and is now trading at $2....
How were Repro-Med Systems' earnings last quarter?
Repro-Med Systems, Inc. (OTCMKTS:REPR) posted its quarterly earnings results on Tuesday, August, 6th. The company reported $0.00 earnings per share...
Who are Repro-Med Systems' key executives?
Repro-Med Systems' management team includes the following people: Mr. Daniel S. Goldberger , Exec. Chairman (Age 60) Mr. Donald B. Pettigrew ,...
Who are some of Repro-Med Systems' key competitors?
Some companies that are related to Repro-Med Systems include Anika Therapeutics (ANIK) , Utah Medical Products (UTMD) , Westaim (WEDXF) , SeaSp...
What other stocks do shareholders of Repro-Med Systems own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Repro-Med Systems investors own include Globus Medical (GM...
What is Repro-Med Systems' stock symbol?
Repro-Med Systems trades on the OTCMKTS under the ticker symbol "REPR."
How do I buy shares of Repro-Med Systems?
Shares of REPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is Repro-Med Systems' stock price today?
One share of REPR stock can currently be purchased for approximately $2.16.
How much money does Repro-Med Systems make?
Repro-Med Systems (OTCMKTS:REPR) has a market capitalization of $86.16 million and generates $17.35 million in revenue each year.
REPR Target Price
Repro-Med Systems, Inc. ( REPR ) Stock Market info
REPR price target in 14 days: 4.205 USD* upside and 3.593 USD* downside. (Highest and lowest possible predicted price in a 14 day period)
Repro-Med Systems, Inc. ( REPR ) Stock Price Prediction, Stock Forecast for next months and years
Recommendations: Buy or sell Repro-Med Systems stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Repro-Med Systems share forecasts, stock quote and buy / sell signals below.
Also on walletinvestor.com
Short-term and long-term REPR (Repro-Med Systems, Inc.) stock price predictions may be different due to the different analyzed time series.
ResMed Announces Participation in the Citi Healthcare Conference
mlower1000_6908 — $6.91 for a current price of this stock? Really? A forecast with erroneous data is worthless.
CCLA Investment Management Ltd Buys PepsiCo Inc, PayPal Holdings Inc, Brookfield Renewable ..
SAN DIEGO, Feb. 16, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Citi Healthcare Conference on Wednesday, February 23, 2022, beginning at approximately 12:30 p.m. (Eastern Standard Time) via webcast.
Here's Why You Should Hold on to ResMed (RMD) Stock for Now
Investment company CCLA Investment Management Ltd (Current Portfolio) buys PepsiCo Inc, PayPal Holdings Inc, Brookfield Renewable Partners LP, Zoetis Inc, The Walt Disney Co, sells Activision Blizzard Inc, Blackstone Inc, NVIDIA Corp, Synopsys Inc, Masco Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, CCLA Investment Management Ltd..
Harfst & Associates, Inc. Buys Cummins Inc, Raytheon Technologies Corp, ResMed Inc, Sells ..
Investors are optimistic about ResMed (RMD) on increased demand for sleep and respiratory care devices on steady recovery of markets from COVID-19 impacts.
Synergy Asset Management, LLC Buys Johnson & Johnson, Global Payments Inc, Ross Stores Inc, ..
Investment company Harfst & Associates, Inc.
ResMed Welcomes Urvashi Tyagi as New Chief Technology Officer
Investment company Synergy Asset Management, LLC (Current Portfolio) buys Johnson & Johnson, Global Payments Inc, Ross Stores Inc, ResMed Inc, Costco Wholesale Corp, sells SPDR Bloomberg 1-3 Month T-Bill ETF, Apple Inc, Amazon.com Inc, Ashland Global Holdings Inc, ProShares Short 20+ Year Treasury during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Synergy Asset Management, LLC..
ResMed (RMD) Q2 Earnings in Line, Revenues Miss Estimates
Urvashi Tyagi, ResMed Chief Technology Officer Urvashi Tyagi, ResMed Chief Technology Officer Tyagi brings over 25 years’ IT and leadership experience from ADP, American Express, Amazon, Microsoft, and IBMCurrent CTO and SaaS President Bobby Ghoshal now transitions to SaaS full-time SAN DIEGO, Feb.
91 Biggest Movers From Yesterday
ResMed's (RMD) Q2 earnings meet estimates, with robust demand for sleep and respiratory care devices driving the top line.
54 Stocks Moving In Thursday's Mid-Day Session
Gainers NuZee, Inc. (NASDAQ: NUZE) shares jumped 164.5% to settle at $5.29 on Thursday. NuZee manufacturing partner, Cuvee Coffee, reported an expansion into select Walmart stores nationwide.
What happened
Gainers Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares gained 42.6% to $9.68. Pioneer Power Solutions recently announced the launch of its E-Boost portfolio of mobile Electric Vehicle charging solutions for a full range of applications.
So what
Shares of Repro Med Systems ( KRMD -3.32% ), which conducts its business as KORU Medical, were sinking 13.4% as of 11 a.m. EST on Tuesday. The decline came after the specialty infusions solutions company provided an update after the market closed on Monday. KORU gave preliminary financial results for full-year 2020.
Now what
Any time a company's CEO departs unexpectedly, investors become nervous. Pettigrew had led Repro Med/KORU Medical for nearly two years. The company's board of directors named former home infusion executive and KORU Medical board member Jim Beck as interim CEO.
Premium Investing Services
Could a positive catalyst be on the way for the healthcare stock after today's big drop? It isn't likely that KORU's fourth-quarter update scheduled for March will help very much considering the company's full-year 2020 preliminary results.
About ResMed
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.
Headlines
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases.
ResMed (NYSE:RMD) Frequently Asked Questions
Harfst & Associates, Inc. Buys Cummins Inc, Raytheon Technologies Corp, ResMed Inc, Sells ... - Yahoo Finance
